利妥昔单抗联合化疗治疗229例滤泡性淋巴瘤患者的预后研究

OBJECTIVE: To explore the clinical characteristics of follicular lymphoma (FL) in the era of rituximab combined with chemotherapy and the prognostic significance of the follicular lymphoma international prognostic index (FLIPI), follicular lymphoma international prognostic index 2 (FLIPI2), internat...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2019
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351707/
https://www.ncbi.nlm.nih.gov/pubmed/30704228
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.01.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351707/
https://www.ncbi.nlm.nih.gov/pubmed/30704228
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.01.009

Ejemplares similares